Pages that link to "Q33624880"
Jump to navigation
Jump to search
The following pages link to Pulmonary function in infants with cystic fibrosis: the effect of antibiotic treatment (Q33624880):
Displaying 29 items.
- Prophylactic anti-staphylococcal antibiotics for cystic fibrosis (Q24187844) (← links)
- Prophylactic anti-staphylococcal antibiotics for cystic fibrosis (Q24202299) (← links)
- Oral anti-pseudomonal antibiotics for cystic fibrosis (Q24202879) (← links)
- Oral anti-pseudomonal antibiotics for cystic fibrosis (Q24243916) (← links)
- Prophylactic anti-staphylococcal antibiotics for cystic fibrosis (Q24248016) (← links)
- Oral anti-pseudomonal antibiotics for cystic fibrosis (Q26471106) (← links)
- Changes in strategies for optimal antibacterial therapy in cystic fibrosis. (Q31876588) (← links)
- Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis (Q33598905) (← links)
- Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis (Q34491552) (← links)
- Monitoring early inflammation in CF. Infant pulmonary function testing (Q34773514) (← links)
- Lung function from infancy to school age in cystic fibrosis (Q34797890) (← links)
- Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis (Q35557791) (← links)
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients (Q35669548) (← links)
- Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests (Q36166307) (← links)
- Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. (Q36924692) (← links)
- Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. (Q37633119) (← links)
- An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age. (Q38100845) (← links)
- Novel end points for clinical trials in young children with cystic fibrosis (Q38111791) (← links)
- Staphylococcus aureus in early cystic fibrosis lung disease (Q38130897) (← links)
- Prophylactic anti-staphylococcal antibiotics for cystic fibrosis. (Q38833258) (← links)
- Early asymptomatic pulmonary changes in infants with cystic fibrosis (Q41690232) (← links)
- Antibacterial therapy outside of Pseudomonas aeruginosa (Q44690837) (← links)
- Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants (Q45143046) (← links)
- DNase in stable cystic fibrosis infants: a pilot study (Q47917780) (← links)
- Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis (Q49016971) (← links)
- Sex-specific prediction equations for Vmax(FRC) in infancy: a multicenter collaborative study (Q49140641) (← links)
- Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis (Q49147380) (← links)
- Pulmonary function in hospitalized infants and toddlers with cystic fibrosis (Q74449870) (← links)
- [Evaluation of respiratory function in infants with cystic fibrosis. Synopsis of the "Respiratory Functional Explorations" working group of the French Society of Cystic Fibrosis (CRCM)] (Q81543544) (← links)